Extending adjuvant letrozole for 5 years after completing an initial 5 years of aromatase inhibitor therapy alone
Extending adjuvant letrozole for 5 years after completing an initial 5 years of aromatase inhibitor therapy alone
Novel daratumumab-based regimen slows multiple myeloma progression
Double stem-cell transplant improves outcomes for children with high-risk neuroblastoma
Latest in hepatocellular carcinoma treatments
Liquid biopsy may help guide treatment decisions for advanced solid tumours
Innovative direct-to-patient outreach may accelerate breast cancer research
Liquid biopsy may help guide treatment decisions for advanced solid tumours
Hypo-fractionation of prostate cancer radiotherapy
Controlled phase III trial of adjuvant combination chemotherapy of gemcitabine and capecitabine, versus monotherapy gemcitabine in patients with resected pancreatic ductal adenocarcinoma
Editor's Choice for May 2016
Hodgkins - update on treatment strategies in children and adolescents
Use of novel agents in childhood ALL